Strategic Acquisition Cure Medical was acquired by ConvaTec in March 2021, indicating integration into a larger medical devices platform. This suggests sales opportunities through ConvaTec's broader distribution channels, existing institutional customers, and cross-sell of Cure’s catheter innovations to a wider base.

Product Differentiation Strong portfolio including closed system and hydrophilic catheters for various users (men, women, children) highlights opportunities to position value propositions around safety, comfort, and ease of use to touchpoints in hospitals, clinics, home care, and durable medical equipment suppliers.

Growth via Partnerships Past collaborations such as with The Rollettes Experience and a broad product launch history (Cure Dextra Closed System) indicate receptiveness to partnerships and advocacy-based marketing; target alliances with patient groups, home health providers, and clinical education programs to expand market access.

Expand Reach Through Digital Active digital stack (Optimizely, Microsoft Advertising, LinkedIn Ads, OneTrust, Hotjar, Azure) suggests readiness for targeted campaigns, AB testing, and lead generation. Leverage digital channels to reach hospitals, clinics, and direct-to-consumer segments, particularly around new product launches.

Low Revenue, High Upsell Current revenue under $1M with a lean team (2-10 employees) presents an opportunity to upsell via ConvaTec distribution, institutional purchasing, and bundled offerings with complementary urology and continence care products, while focusing on high-margin improvements and scalable partnerships.